In a study where podocyte dysfunction was induced through hyperhomocysteinemia, GH limited glomerulosclerosis by inhibiting the nicotinamide adenine dinucleotide phosphate (NADP) pathway [44]. This evidence concerns the gene GH1 and glomerulosclerosis.